Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Melius Research is an independent equity research firm headquartered in New York City, specializing in providing deep-dive fundamental analysis to institutional investors. Founded in 2017 by a group of veteran Wall Street analysts, the firm covers several key sectors, including Healthcare, Industrials, Technology, and Energy. Within the healthcare space, Melius Research offers comprehensive insights into biotechnology, pharmaceuticals, and life sciences, focusing on clinical trial outcomes, regulatory developments, and commercial potential. The firm is recognized for its data-centric approach and its ability to provide differentiated investment perspectives in complex markets. Melius operates as a boutique research house, prioritizing objective analysis to help investors navigate the rapidly evolving biopharma landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Melius Research.